Taylor Wessing advised Essential Pharma on its acquisition of European rights to Colobreathe. International specialty pharmaceutical company, Essential Pharma, has acquired the European rights to Colobreathe...
Essential Pharma’s Acquisition of European Rights to Colobreathe
Essential Pharma’s Acquisition of Ocular And Postpartum Therapies From Novartis
Lenz & Staehelin advised Essential Pharma in this transaction. Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights...